The largest community of pharma leaders

Aviceda Therapeutics Announces Formation of Executive Team

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, a late-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing the composition of the Executive Team that will guide the company through ongoing development of breakthrough, first-in-class therapeutics and continued growth opportunities as a business entity. Servin
Source Read More

Recent Articles